Twenty-five years ago, the bestseller “The Tipping Point” turned Malcolm Gladwell into a household name. Describing “the critical mass, the threshold, the boiling point,” Gladwell illustrates ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to local medical professionals. "I think it could be a potentially ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Aims to revolutionize pharmaceutical manufacturing with focus on advanced aseptic processing technology.

Gibson called for more funds to be allocated for mobile units to care for drug users in the Bronx; Naloxone training for residents and caregivers; and an ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

Multiple states have reached a tentative new agreement with the Sackler family, who made billions of dollars marketing OxyContin, the drug that set off the U.S. opioid crisis. New York State Attorney ...